A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

Cited by (279)

Items 101–200 of 279

1. Mesoporous ZnO nanocapsules for the induction of enhanced antigen-specific immunological responses
   Sumbul Afroz, Himadri Medhi, Somedutta Maity, Gillipsie Minhas, Srikanth Battu, Jeevan Giddaluru, Koushi Kumar, Pradip Paik, Nooruddin Khan · 2017 · Nanoscale
2. Current status and future prospects for the development of substance abuse vaccines
   R. David Heekin, Daryl I. Shorter, Thomas R. Kosten · 2017 · Expert Review of Vaccines
3. Antigen Delivery By virus-like Particles for Immunotherapeutic Vaccination
   Farah Al-Barwani, Braeden Donaldson, Simon J. Pelham, Sarah L. Young, Vernon K. Ward · 2014 · Therapeutic Delivery
4. The genetics of nicotine addiction liability: ethical and social policy implications
   Wayne Hall, CORAL E. GARTNER, Adrian Carter · 2008 · Addiction
5. Smoking Cessation Interventions in Clinical Practice
   Jacques Cornuz · 2007 · European Journal of Vascular and Endovascular Surgery
6. Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
   Marco Palma · 2023 · Vaccines
7. Protein Cage Nanoparticles as Delivery Nanoplatforms
   Bongseo Choi, Hansol Kim, Hyukjun Choi, Sebyung Kang · 2018 · Advances in experimental medicine and biology
8. Enhancing nicotine vaccine immunogenicity with liposomes
   Jonathan W. Lockner, Sam On Ho, Karen C. McCague, Su Ming Chiang, Thai Q. Do, Gary Fujii, Kim D. Janda · 2012 · Bioorganic & Medicinal Chemistry Letters
9. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2
   Mohsen Hemmati-Dinarvand, Mohsen Hemmati-Dinarvand, Marziye Karimzade, Daria Anna Rutkowska, Mohammad Hadi Eskandari, Sayyad Khanizadeh, Alireza Afsharifar · 2021 · Biotechnology Letters
10. Vaccine for hypertension: Modulating the renin–angiotensin system
    Rabindra Pandey, Wu Yong Quan, Fang Hong, Su Li jie · 2009 · International Journal of Cardiology
11. Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine
    Hong Zheng, Yun Yu Hu, Wei Chieh Huang, Sabina De Villiers, Paul R. Pentel, Jianfei Zhang, Harry C. Dorn, Marion F. Ehrich, Chenming Zhang · 2015 · Journal of Biomedical Nanotechnology
12. Targeting nicotine addiction: the possibility of a therapeutic vaccine
    José Juan Escobar‐Chávez · 2011 · Drug Design Development and Therapy
13. Immunization against angiotensins for the treatment of hypertension
    Patrik Maurer, Martin F. Bachmann · 2009 · Clinical Immunology
14. Pharmacotherapy for Tobacco Dependence
    Reginald V. Fant, August R. Buchhalter, Albert C. Buchman, Jack E. Henningfield · 2009 · Handbook of experimental pharmacology
15. Pharmacokinetic approaches to treatment of drug addiction
    David A. Gorelick · 2008 · Expert Review of Clinical Pharmacology
16. Is immunotherapy an opportunity for effective treatment of drug addiction?
    Jadwiga Zalewska-Kaszubska · 2015 · Vaccine
17. Virus-like particle-based nanocarriers as an emerging platform for drug delivery
    Bingchuan Yuan, Yang Liu, Meilin Lv, Yilei Sui, Shenghua Hou, Tinghui Yang, Zakia Belhadj, Yulong Zhou, Naidan Chang, Yachao Ren et al. · 2023 · Journal of drug targeting
18. Current status of vaccines for substance use disorders: A brief review of human studies
    Thanh Thuy Truong, Thomas R. Kosten · 2021 · Journal of the Neurological Sciences
19. Virus-Like Particles, a Versatile Subunit Vaccine Platform
    Braeden Donaldson, Farah Al-Barwani, V. Young, S. Scullion, V. Ward, S. Young · 2014 · Subunit Vaccine Delivery
20. Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
    David A. G. Skibinski, Brendon John Hanson, Yu-Fang Lin, Veronika von Messling, Andrea Jegerlehner, Jason Boon Sern Tee, De Hoe Chye, Steven K. K. Wong, Amanda A. P. Ng, Hui Yin Lee et al. · 2013 · PLoS ONE
21. A second vaccine revolution for the new epidemics of the 21st century
    Mark R. Dyer, Wolfgang A. Renner, Martin F. Bachmann · 2006 · Drug Discovery Today
22. Differential Effects of Passive Immunization with Nicotine-Specific Antibodies on the Acute and Chronic Distribution of Nicotine to Brain in Rats
    Paul R. Pentel, M.B. Dufek, Samuel A. Roiko, Mark G. LeSage, Daniel E. Keyler · 2006 · Journal of Pharmacology and Experimental Therapeutics
23. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice
    Alexandra Fowler, Maureen L. Sampson, Alan Thomas Remaley, Bryce Chackerian · 2021 · Vaccine
24. Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice
    Bhupal Ban, Rodell C. Barrientos, Therese Oertel, Essie Komla, Connor Whalen, Megan S. Sopko, Yingjian You, Partha Banerjee, Agnieszka Sulima, Arthur E. Jacobson et al. · 2021 · mAbs
25. Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice
    Yu Zou, Ivo Sonderegger, Gerd Lipowsky, Gary T. Jennings, Nicole Schmitz, Marco Landi, Manfred Köpf, Martin F. Bachmann · 2010 · Vaccine
26. Interventions to prevent periodontal disease in tobacco‐, alcohol‐, and drug‐dependent individuals
    Purnima Kumar · 2020 · Periodontology 2000
27. Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder
    Michael D. Raleigh, S.J. King, Federico Baruffaldi, Amy T. Saykao, Fatima Alamin Awad Alkareem Hamid, S Winston, Mark G. LeSage, P.R. Pentel, Marco Pravetoni · 2021 · Neuropharmacology
28. Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion
    Luigia Cappelli, Paolo Cinelli, Fabiola Giusti, Ilaria Ferlenghi, Sabrina Utrio Lanfaloni, Newton Wahome, Matthew J. Bottomley, Domenico Maione, Roberta Cozzi · 2022 · PLoS ONE
29. Anti-nicotine abuse vaccines in the pipeline: an update
    Erich H. Cerny, Thomas Cerny · 2008 · Expert Opinion on Investigational Drugs
30. The future of vaccines in the management of addictive disorders
    Frank M. Orson, Berma M. Kinsey, Rana A. K. Singh, Yan Ling Wu, Tracie J. Gardner, Thomas R. Kosten · 2007 · Current Psychiatry Reports
31. Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env
    Jonelle L. Mattiacio, Scott Walter, Matt Brewer, William Domm, Alan E. Friedman, Stephen Dewhurst · 2011 · Vaccine
32. Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
    Xiajun Hu, Yihuan Deng, Xiao Chen, Yanzhao Zhou, Hongrong Zhang, Hailang Wu, Shijun Yang, Fen Chen, Zihua Zhou, Min Wang et al. · 2017 · Scientific Reports
33. Vaccines in the management of hypertension
    Thong Huy, Yijia Chen, Van Dong Nguyen, Sorot Phisitkul · 2010 · Expert Opinion on Biological Therapy
34. Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
    Alemu Tekewe Mogus, Lihong Liu, Manxue Jia, Diane T. Ajayi, Kai Y. Xu, Rui Kong, Jing Huang, Jian Yu, VRC Production Program, Peter D. Kwong et al. · 2020 · Vaccines
35. Emerging pharmacotherapies for smoking cessation
    Candice L. Garwood, Lisa A. Potts · 2007 · American Journal of Health-System Pharmacy
36. Tratamiento del Tabaquismo
    Sergio Bello · 2011 · Revista chilena de cardiología
37. Suppression of Nicotine-Induced Pathophysiology by an Adenovirus Hexon-Based Antinicotine Vaccine
    Jonathan B. Rosenberg, Bishnu P. De, Martin Joseph Hicks, Kim D. Janda, Stephen M. Kaminsky, Stefan Worgall, Ronald G. Crystal · 2013 · Human Gene Therapy
38. Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine
    Yun Yu Hu, Daniel Smith, Zongmin Zhao, Theresa M. Harmon, Paul R. Pentel, Marion F. Ehrich, Chenming Zhang · 2019 · Nanomedicine Nanotechnology Biology and Medicine
39. Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder
    Fatima Alamin Awad Alkareem Hamid, Cheryl L. Marker, Michael D. Raleigh, Aaron Khaimraj, Scott Winston, Paul R. Pentel, Marco Pravetoni · 2022 · Vaccine
40. Rip it, stitch it, click it: A Chemist's guide to VLP manipulation
    Yalini H. Wijesundara, Fabian C. Herbert, Sneha Kumari, Thomas Sinclair Howlett, Shailendra Koirala, Orikeda Trashi, Ikeda Trashi, Noora M. Al‐Kharji, Jeremiah J. Gassensmith · 2022 · Virology
41. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies
    Jennifer L. Oliver, Ghazaleh Pashmi, Paul Barnett, Pascal Mettens, Ralph Biemans, Philippe Monteyne, Rémi Palmantier, Timothy C. Gallagher, Sharn Ramaya, Susan Wonnacott · 2007 · Vaccine
42. Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
    Erwan Atcheson, Arturo Reyes‐Sandoval · 2020 · Vaccine
43. Vaccines as Immunotherapies for Substance Use Disorders
    Thomas R. Kosten · 2024 · American Journal of Psychiatry
44. Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines
    Alexander Link, Martin F. Bachmann · 2010 · Immunotherapy
45. ssRNA Phages: Life Cycle, Structure and Applications
    Kaspars Tārs · 2020 · Springer eBooks
46. Review: Pharmacotherapy for smoking cessation
    Laura Carrozzi, Francesco Pistelli, Giovanni Viegi · 2008 · Therapeutic Advances in Respiratory Disease
47. Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron
    Antonina Naskalska, Ewa Szołajska, Laurence Chaperot, J. Angel, Joël Plumas, Jadwiga Chroboczek · 2009 · Vaccine
48. Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier
    Xia Zhao, Limin Chen, Jittima Amie Luckanagul, Xiaolei Zhang, Yuan Lin, Qian Wang · 2015 · ChemBioChem
49. Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein
    Wei Wang, Xiaochun Chen, Chunyi Xue, Yichao Du, Lishan Lv, Qiliang Liu, Xiaoming Li, Yun Ma, Huifang Shen, Yongchang Cao · 2012 · Vaccine
50. Vaccines to combat smoking
    Rick A. Bevins, Jamie L. Wilkinson, Sam D. Sanderson · 2008 · Expert Opinion on Biological Therapy
51. A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective
    Larissa Vuitika, Nelson Côrtes, Vanessa Barbosa Malaquias, Jaqueline Wang da Silva, Aline Aparecida de Lima Lira, Wasim Aluísio Prates-Syed, Lena F. Schimke, Daniela Luz, Ricardo Durães‐Carvalho, Andrea Balan et al. · 2024 · Scientific Reports
52. Viral protein-based nanoparticles (part 2): Pharmaceutical applications
    Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas, Marcos García-Fuentes · 2023 · European Journal of Pharmaceutical Sciences
53. Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients
    Andrew J. Gale, Darlene J. Elias, Patricia M. Averell, Paul S. Teirstein, Mitchell Buck, Steven D. Brown, Zinaida Polonskaya, Andrew K. Udit, M. G. Finn · 2011 · Thrombosis Research
54. A research agenda for assessing the potential contribution of genomic medicine to tobacco control
    Wayne Hall · 2007 · Tobacco Control
55. Next-generation viral nanoparticles for targeted delivery of therapeutics: Fundamentals, methods, biomedical applications, and challenges
    Jia-Sen Tan, Muhamad Norizwan Bin Jaffar Ali, Bee-Ko-On Gan, W. Tan · 2023 · Expert Opinion on Drug Delivery
56. Biotechnology and the Treatment of Addictive Disorders
    Ahmed M. Elkashef, Jamie Biswas, Jane B. Acri, Frank J. Vocci · 2007 · BioDrugs
57. Bacteriophage Virus-Like Particles: Platforms for Vaccine Design
    Ebenezer Tumban · 2023 · Methods in molecular biology
58. Different Binding Modes of Free and Carrier-Protein-Coupled Nicotine in a Human Monoclonal Antibody
    Kaspars Tārs, Svetlana Koteloviča, Gerd Lipowsky, Monika Bauer, Roger R. Beerli, Martin F. Bachmann, Patrik Maurer · 2011 · Journal of Molecular Biology
59. A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
    Erwan Atcheson, Adrian V. S. Hill, Arturo Reyes‐Sandoval · 2021 · npj Vaccines
60. Escherichia coli-Based Cell-Free Protein Synthesis for Iterative Design of Tandem-Core Virus-Like Particles
    Noelle Colant, Beatrice Melinek, Stefanie Frank, William M. Rosenberg, Daniel G. Bracewell · 2021 · Vaccines
61. A simple physiologically based pharmacokinetic model evaluating the effect of anti-nicotine antibodies on nicotine disposition in the brains of rats and humans
    Kyle Saylor, Chenming Zhang · 2016 · Toxicology and Applied Pharmacology
62. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route
    Xingmei Qi, Qian Lu, Jingping Hu, Sidong Xiong · 2019 · Microbial Cell Factories
63. Therapeutic options and challenges for substances of abuse
    Tracie J. Gardner, Thomas R. Kosten · 2007 · Dialogues in Clinical Neuroscience
64. Immunotherapeutic strategies for treating opioid use disorder and overdose
    Rachel R. Luba, Suky Martinez, Jermaine D. Jones, Marco Pravetoni, Sandra D. Comer · 2023 · Expert Opinion on Investigational Drugs
65. Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity
    Roberto Scendoni, Emanuele Bury, Isabella Lima Arrais Ribeiro, Roberto Cameriere, Mariano Cingolani · 2022 · Human Vaccines & Immunotherapeutics
66. Viruses and Virus-Like Particles in Biotechnology
    António Roldão, Ana Carina Silva, Maria Cândida M. Mellado, Paula M. Alves, Manuel J.T. Carrondo · 2011 · Elsevier eBooks
67. Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides
    David F. Zeigler, Richard Roque, Christopher H. Clegg · 2017 · PLoS ONE
68. Treatment of methamphetamine abuse: An antibody-based immunotherapy approach
    Yun‐Hsiang Chen, Kuang‐Lun Wu, Ho-Min Tsai, Chia‐Hsiang Chen · 2013 · Journal of Food and Drug Analysis
69. Beyond Passive Immunization: Toward a Nanoparticle-Based IL-17 Vaccine as First in Class of Future Immune Treatments
    John Foerster, Martin Bachman · 2015 · Nanomedicine
70. Intranasal delivery of a nicotine vaccine candidate induces antibodies in mouse blood and lung mucosal secretions that specifically neutralize nicotine
    Riyad F. Alzhrani, Haiyue Xu, Solange A. Valdes, Zhengrong Cui · 2020 · Drug Development and Industrial Pharmacy
71. Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies
    Michael D. Raleigh, Nicola Beltraminelli, Stephanie Fallot, Mark G. LeSage, Amy T. Saykao, Paul R. Pentel, Steve Fuller, Thomas Thisted, Zuzanna Biesova, Stephen K. Horrigan et al. · 2021 · PLoS ONE
72. A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects
    Muhammet A. Celik, Brian Fuehrlein · 2022 · ImmunoTargets and Therapy
73. Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like Particles
    Fatemeh Shafieichaharberoud, Shuyao Lang, Connor Whalen, Cristina Rivera Quiles, Lillie Purcell, Cameron Talbot, Pengfei Wang, Elizabeth B. Norton, Michelle S. Mazei‐Robison, Agnieszka Sulima et al. · 2023 · Bioconjugate Chemistry
74. Virus-Like Particles-Based Mucosal Nanovaccines
    Sergio Rosales‐Mendoza, Omar González‐Ortega · 2019 · Springer eBooks
75. Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice
    Yun‐Hsiang Chen, Kuang‐Lun Wu, Kun-Lieh Wu, Kun-Lieh Wu, Ho-Min Tsai, Mao-Liang Chen, Yi-Wei Chen, Wei Hsieh, Chun-Ming Lin, Yun Wang · 2017 · Scientific Reports
76. A programmable smoke delivery device for PET imaging with cigarettes containing 11C-nicotine
    Yantao Zuo, Pradeep Garg, Rachid Nazih, Sudha Garg, Jed E. Rose, Thangaraju Murugesan, Alexey G. Mukhin · 2017 · Journal of Neuroscience Methods
77. Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors
    Courtney M. Keller, Allyson L. Spence, Misty W. Stevens, Samuel Michael Owens, Glenn F. Guerin, Nicholas E. Goeders · 2019 · Psychopharmacology
78. Animal Tissue Culture
    Anju Verma · 2013 · Elsevier eBooks
79. The Neurobiology of Nicotine Addiction: Clinical and Public Policy Implications
    Paul D Gardner, Andrew R. Tapper, Jean Anne King, Joseph R. DiFranza, Douglas M. Ziedonis · 2009 · Journal of Drug Issues
80. The Application of Adaptive Model Predictive Control for Fed-Batch Escherichia coli BL21 (DE3) Cultivation and Biosynthesis of Recombinant Proteins
    Konstantīns Dubencovs, Artūrs Šuleiko, Elīna Sīle, Ivars Petrovskis, Ināra Akopjana, Anastasija Šuleiko, Vytautas Galvanauskas, Kaspars Tārs, Juris Vanags · 2023 · Fermentation
81. Substructure-Specific Antibodies Against Fentanyl Derivatives
    Asheley Poole Chapman, Minghao Xu, Michelle Schroeder, Jason M. Goldstein, Asiya Seema Chida, Joo R. Lee, Xiaoling Tang, Rebekah E. Wharton, M. G. Finn · 2025 · ACS Nano
82. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat
    David H. Malin, William D. Moon, Pilar Goyarzu, N. Magallanes, M. B. Blair, Matthew R. Alexander, Lauren McDavid, J. L. Spurgeon, Sofiane Ennifar, Ali Fattom · 2010 · Nicotine & Tobacco Research
83. Immunotherapy of 436 Morphine Addicts by Therapeutic Morphine Vaccine in Kerman Province (I.R. Iran)
    Ali Akbar Farhangi · 2012 · Journal of Vaccines & Vaccination
84. Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles
    Mansi Purwar, Jonathan K. Pokorski, Pranveer Singh, Sanchari Bhattacharyya, Heather E. Arendt, Joanne DeStefano, Celia C. LaBranche, David C. Montefiori, M. G. Finn, Raghavan Varadarajan · 2018 · Vaccine
85. Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats
    Reynaldo Oliva, Nya L. Fraleigh, Jordan D. Lewicky, Mildrey Fariñas, Tamara Hernández, Alexandrine L. Martel, Ingrid Navarro, Dagmar García-Rivera, Reinaldo Acevedo, Hoang‐Thanh Le · 2019 · Pharmaceutics
86. Treating tobacco use and dependence in clinical practice
    Jacques Cornuz · 2006 · Expert Opinion on Pharmacotherapy
87. Immunotherapy for Polyomaviruses: Opportunities and Challenges
    Tina Dalianis · 2012 · Immunotherapy
88. Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses
    Nicolas Dérian, Bertrand Bellier, Hang‐Phuong Pham, Eliza Tsitoura, Dorothea Kazazi, Christophe Huret, Penelope Mavromara, David Klatzmann, Adrien Six · 2016 · PLoS Computational Biology
89. Nicotine Conjugate Vaccine as a Novel Approach to Smoking Cessation
    Anne R. Ottney · 2011 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
90. Scientific overview: 2013 BBC plenary symposium on tobacco addiction
    Mariella De Biasi, I. McLaughlin, Erika E. Perez, Peter Anthony Crooks, Linda P. Dwoskin, Michael Thomas Bardo, Paul R. Pentel, Dorothy K. Hatsukami · 2014 · Drug and Alcohol Dependence
91. Safety and immunogenicity of the anti-cocaine vaccine UFMG-VAC-V4N2 in a non-human primate model
    Brian Sabato, Paulo Sérgio de Almeida Augusto, Raíssa Lima Gonçalves Pereira, Felipe Coutinho Batista Esteves, Sordaini Maria Caligiorne, Bruna Rodrigues Dias Assis, Sóstenes Apolo Correia Marcelino, Larissa Pires do Espírito Santo, Karine Dias dos Reis, Leonardo da Silva Neto et al. · 2023 · Vaccine
92. Synthesis of 4-[2-Aminoethyl(nitrosamino)]-1-pyridin-3-yl-butan-1-one, a New NNK Hapten for the Induction of N-Nitrosamine-Specific Antibodies
    Emmanuel J. F. Prodhomme, Corinne Ensch, Fabienne B. Bouche, Thomas Kaminski, Sabrina Deroo, Pierre Seck, Gilbert Kirsch, Claude P. Muller · 2007 · Bioconjugate Chemistry
93. Preventing Sin: The Ethics of Vaccines Against Smoking
    Sarah R. Lieber, Joseph Millum · 2013 · The Hastings Center Report
94. Symmetry-Directed Design of Protein Cages and Protein Lattices and Their Applications.
    Aaron Sciore, E. N. G. Marsh · 2017 · Sub-cellular biochemistry
95. Current status of vaccines in psychiatry—A narrative review
    Pooja Patnaik Kuppili, Harshini Manohar, Vikas Menon · 2018 · Asian Journal of Psychiatry
96. Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019
    Halle Lutz, Kristen D. Popowski, Phuong‐Uyen Dinh, Ke Cheng · 2020 · Advanced NanoBiomed Research
97. A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood
    Isabella G. Romano, Susan B. Core, Naomi Lee, Curtis Mowry, Koen K. A. Van Rompay, Yumei Huang, Bryce Chackerian, Kathryn M. Frietze · 2023 · Vaccine
98. Nicotine conjugate vaccines: A novel approach in smoking cessation
    Caroline M. Kitchens, Stephan L. Foster · 2012 · Journal of the American Pharmacists Association
99. Vaccines in the Treatment of Substance Abuse
    Daryl I. Shorter, Thomas R. Kosten · 2011 · FOCUS The Journal of Lifelong Learning in Psychiatry
100. Immunotherapeutic Polyoma and Human Papilloma Virus-Like Particles
     Torbjörn Ramqvist, Tina Dalianis · 2009 · Immunotherapy